Memoral Sloan Kettering Cancer Center

Basking Ridge, New Jersey 07920

0 studies enrolling now · 47 studies all time

What they study most

Advanced Gastrointestinal Stromal Tumor (GIST), Advanced Lung Cancer, Bladder Cancer, Brain Cancer, Brain Metastases, Breast Cancer, CNS Cancer, Cancer, Central Nervous System (CNS) Metastases, Colon Cancer, Colorectal Cancer, EGFR-Mutant Lung Cancer

Studies at this site

• Combination Therapy With Carfilzomib, Romidepsin, Lenalidomide in Patients With Relapsed or Refractory B- and T-cell Lymphomas — Completed
• A Phase 1/2 Trial of Trametinib and Erlotinib in Patients With EGFR-Mutant Lung Adenocarcinomas and Acquired Resistance to Erlotinib — Completed
• Phase II Trial of Pembrolizumab With Trastuzumab and Chemotherapy in Advanced HER2 Positive Esophagogastric (EG) Cancer — Completed
• Longitudinal Assessment of Health-Related Quality of Life in Men With Localized Prostate Cancer — Completed
• 18F-FLT-PET Imaging of the Brain in Patients With Metastatic Breast Cancer to the Brain Treated With Whole Brain Radiation Therapy With or Without Sorafenib: Comparison With MR Imaging of the Brain — Completed
• Lenalidomide Intensification in Patients With Serologic/Asymptomatic Progression of Multiple Myeloma While on Lenalidomide Maintenance — Completed
• Screening Trial of Nivolumab With Image Guided, Stereotactic Body Radiotherapy (SBRT) Versus Nivolumab Alone in Patients With Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) — Completed
• Whole Brain Radiotherapy (WBRT) With Sorafenib for Breast Cancer Brain Metastases (BCBM) — Completed
• 3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomy — Completed
• Intermittent High-Dose Lapatinib in Tandem With Capecitabine for HER2 Overexpressed/Amplified Metastatic Breast Cancer With Central Nervous System (CNS) Metastases — Completed
• Nintedanib in Patients With Advanced Esophagogastric Cancer — Completed
• A Single Center Randomized Controlled Trial Assessing Pain and Quality of Life Following Surgery — Completed
• Crizotinib and Ganetespib (STA-9090) in ALK Positive Lung Cancers — Completed
• Telemedicine Evaluation for Stem Cell Transplant Patients — Completed
• Bortezomib in KRAS-Mutant Non-Small Cell Lung Cancer in Never Smokers or Those With KRAS G12D — Completed
• FOLFOX Plus Regorafenib in Patients With Unresectable or Metastatic Esophagogastric Cancer — Completed
• BGJ398 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST) — Completed
• Phase II Study of Ramucirumab With Chemotherapy in Patients With Metastatic Gastroesophageal Junction and Gastric Cancer — Stopped early
• Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma — Completed
• Electronic Reporting of Symptoms After Surgery — Completed
• Functional and Aesthetic Outcomes After Mandible Reconstruction With Fibula Osteomyocutaneous Free Flaps — Completed
• Acute Normovolemic Hemodilution in Patients Undergoing Cytoreductive Surgery for Advanced Ovarian Cancer — Completed
• Lenalidomide (Revlimid®) Plus Low-dose Dexamethasone (Ld x 4 Cycles) Then Stem Cell Collection Followed by Randomization to Continued Ld or Stem Cell Transplantation (SCT) Plus Maintenance L — Completed
• Trial of Ruxolitinib and Erlotinib in Patients With EGFR-mutant Lung Adenocarcinoma With Acquired Resistance to Erlotinib — Completed
• Low Dose Daily Erlotinib in Combination With High Dose Twice Weekly Erlotinib in Patients With EGFR-Mutant Lung Cancer — Completed
• Neoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-small Cell Lung Cancer With Switch to Chemotherapy Alternative in Nonresponders (NEOSCAN) — Completed
• Long-Term Impact of Human Papillomavirus (HPV) on Quality of Life — Completed
• Local Therapies for Oligometastatic Non-Small Cell Lung Cancer Harboring Sensitizing EGFR Mutations — Completed
• A Multicenter Trial On The Utility and Impact Of Computed Tomography and Serum CA-125 In the Management of Newly Diagnosed Ovarian Cancer — Completed
• Bevacizumab, Temozolomide and Hypofractionated Radiotherapy for Patients With Newly Diagnosed Malignant Glioma — Completed
• Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL) — Completed
• Cabozantinib (XL184) in Patients With Relapsed or Refractory Myeloma — Completed
• Gemcitabine and Pazopanib in Chemotherapy Naïve Patients With Advanced/Metastatic Urothelial Carcinoma Ineligible for Cisplatin-based Chemotherapy — Stopped early
• Combination of the Hedgehog Inhibitor, LDE225, With Etoposide and Cisplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) — Completed
• Detection of Oncogenic Tumor Mutations in the Urine and Blood of Lung and Colorectal Cancer Patients — Completed
• Study of Economic Circumstances, Service Utilization, and Service Needs Among Older Colon Cancer Patients — Completed
• Temozolomide for Relapsed Sensitive or Refractory Small Cell Lung Cancer — Completed
• Study of Docetaxel, Cisplatin, and Fluorouracil (Modified DCF) With Bevacizumab in Patients With Unresectable or Metastatic Gastroesophageal Adenocarcinoma — Completed
• Study of Gemcitabine, Carboplatin, and Panitumumab (GCaP) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer — Stopped early
• Registry for Patients With Acquired Resistance to Small Molecule Kinase Inhibitors in Non-Small-Cell Lung Cancer — Completed
• Vitamin D Levels in Stage IV Colorectal Cancer Patients — Completed
• Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma — Completed
• Phase II Trial of Gemcitabine, Carboplatin, and Bevacizumab in Chemotherapy Naive Patients With Advanced/Metastatic Urothelial Carcinoma — Completed
• Study of Pralatrexate With Vitamin B12 and Folic Acid Supplementation for Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC) — Completed
• Cetuximab in Patients With Lung Adenocarcinoma Receiving Erlotinib That Have Developed "Acquired Resistance" to Erlotinib — Completed
• Survey and Blood Sample Collection for Patients With Lung Cancer Who Never Smoked Cigarettes — Completed
• Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast Cancer — Completed